Standard BioTools Inc
Research Standard BioTools Inc (LAB) on Bullrun: market cap USD 254.88M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerLAB
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 254.88M
- Financial periodQ2 2026
- RevenueUSD 20.10M
- Net income-USD 26.76M
- Free cash flow-USD 10.66M
- Gross margin52.4%
Valuation Snapshot
latest market cap is USD 254.88M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 85.33M | -USD 74.90M | -USD 82.65M | 49.9% | -0.2 | USD 120.86M | USD 30.83M | USD 424.29M |
| FY2024 | USD 91.01M | -USD 138.89M | -USD 151.81M | 49.3% | -0.52 | USD 166.73M | USD 299.00K | USD 471.72M |
| FY2023 | USD 106.34M | -USD 74.66M | -USD 46.12M | 47.4% | -0.94 | USD 51.70M | USD 63.51M | -USD 148.05M |
| FY2022 | USD 97.95M | -USD 190.10M | -USD 93.20M | 37.8% | -2.43 | USD 81.31M | USD 64.89M | -USD 81.47M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 254.88M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 494.57M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 660.68M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 176.87M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 92.78M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 301.52M | n/a | n/a | n/a |
About Standard BioTools Inc
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Standard BioTools Inc's market cap?
Standard BioTools Inc's market capitalization is USD 254.88M.
What does Standard BioTools Inc do?
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses.